Jasper Therapeutics Ownership | Who Owns Jasper Therapeutics?
Jasper Therapeutics Ownership Summary
Jasper Therapeutics is owned by 54.01% institutional investors, 2.55% insiders, and 43.44% retail investors. Velan capital investment management lp is the largest institutional shareholder, holding 13.92% of JSPR shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.85% of its assets in Jasper Therapeutics shares.
JSPR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Jasper Therapeutics | 54.01% | 2.55% | 43.44% |
| Sector | Healthcare Stocks | 129.28% | 12.06% | -41.34% |
| Industry | Biotech Stocks | 181.42% | 11.67% | -93.09% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Velan capital investment management lp | 2.67M | 13.92% | $2.34M |
| Millennium management | 1.62M | 8.44% | $1.42M |
| Vanguard group | 1.33M | 8.00% | $2.43M |
| Acorn capital advisors | 1.41M | 7.36% | $1.24M |
| Kingdon capital management | 1.35M | 7.05% | $1.18M |
| Affinity asset advisors | 1.85M | 6.45% | $1.07M |
| Qiming u.s. ventures management | 928.96K | 6.18% | $2.21M |
| Rock springs capital management lp | 1.10M | 5.74% | $964.46K |
| Vanguard capital management | 1.17M | 4.08% | $679.77K |
| Carlyle group | 1.07M | 3.72% | $618.39K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Qiming u.s. ventures management | 928.96K | 3.97% | $2.21M |
| Lion point capital, lp | 465.00K | 2.44% | $407.43K |
| Velan capital investment management lp | 2.67M | 1.46% | $2.34M |
| Acorn capital advisors | 1.41M | 0.35% | $1.24M |
| Kingdon capital management | 1.35M | 0.13% | $1.18M |
| Rock springs capital management lp | 1.10M | 0.06% | $964.46K |
| Affinity asset advisors | 1.85M | 0.04% | $1.07M |
| Diker management | 35.00K | 0.03% | $30.67K |
| Quarry lp | 131.53K | 0.02% | $115.25K |
| Armistice capital | 348.00K | 0.01% | $828.24K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Affinity asset advisors | 1.85M | 0.04% | 1.85M |
| Kingdon capital management | 1.35M | 0.13% | 1.35M |
| Millennium management | 1.62M | 0.00% | 543.75K |
| Verition fund management | 404.99K | 0.00% | 404.99K |
| Armistice capital | 348.00K | 0.01% | 348.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | - | - | -1.75M |
| Woodline partners lp | - | - | -1.04M |
| Propel bio management | - | - | -1.03M |
| T. rowe price investment management | - | - | -964.75K |
| Braidwell lp | - | - | -714.66K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Affinity asset advisors | 1.85M | 0.04% | 1.85M | $1.07M |
| Verition fund management | 404.99K | 0.00% | 404.99K | $234.90K |
| Armistice capital | 348.00K | 0.01% | 348.00K | $828.24K |
| Landscape capital management | 236.64K | 0.01% | 236.64K | $137.25K |
| Barclays | 61.53K | - | 61.53K | $35.69K |
Sold Out
| Holder | Change |
|---|---|
| Rossby financial, lcc | -2.00 |
| Optiver b.v. | -7.00 |
| Sterling capital management | -12.00 |
| Wolff wiese magana | -15.00 |
| Coldstream capital management | -38.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 55 | 17.02% | 15,498,776 | 29.14% | 54 | 3.09% | 28 | 133.33% | 4 | -73.33% |
| Jun 30, 2026 | 47 | -21.67% | 12,001,864 | -24.10% | 41 | 1.37% | 12 | -57.14% | 15 | 15.38% |
| Mar 31, 2026 | 13 | -77.59% | 2,543,150 | -86.77% | 13 | 0.10% | 6 | -81.82% | 4 | -63.64% |
| Dec 31, 2025 | 7 | -89.06% | 1,540,911 | -92.35% | 9 | 0.05% | 3 | -90.91% | 2 | -88.89% |
| Sep 30, 2025 | 12 | -80.33% | 3,749,017 | -66.07% | 24 | 0.46% | 6 | -81.82% | 3 | -78.57% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Polar Capital Healthcare Opports Inc | 581.54K | 3.85% | - |
| Vanguard Total Stock Mkt Idx Inv | 833.39K | 2.98% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 833.39K | 2.98% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 833.39K | 2.50% | - |
| Franklin Biotechnology Discv A(acc)USD | 339.25K | 2.26% | - |
| iShares Russell 2000 ETF | 285.63K | 1.90% | - |
| HBM Healthcare Investments AG Ord | 250.00K | 1.67% | - |
| T. Rowe Price U.S. SC Value Eq Tr-Z | 245.81K | 1.64% | 217.41K |
| T. Rowe Price Small-Cap Value | 394.02K | 1.41% | -154.27K |
| Fidelity Select Health Care | 208.04K | 1.39% | 208.04K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 20, 2026 | Ros Matthew E | Chief Operating Officer | Buy | - |
| Jul 20, 2026 | Crutcher Patrick J | - | Buy | - |
| Sep 22, 2025 | WIGGANS THOMAS G | - | Buy | $99.63K |
| Sep 22, 2025 | WIGGANS THOMAS G | - | Buy | $119.72K |
| Sep 22, 2025 | Lucas Svetlana | - | Buy | $58.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | 2 | - |
| 2026 Q1 | - | - |
| 2025 Q3 | 8 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
JSPR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools